General Information of Drug Transporter (DTP) (ID: DTG5H76)

DTP Name Sodium/hydrogen exchanger 1 (SLC9A1)
Gene Name SLC9A1
UniProt ID
P19634 (SL9A1_HUMAN)
VARIDT ID
DTD0481
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Synonyms APNH; APNH1; LIKNS; NHE-1; NHE1; Na(+)/H(+) antiporter, amiloride-sensitive; Na(+)/H(+) exchanger 1; PPP1R143; SLC9A1; Solute carrier family 9 member 1
DTP Family Monovalent Cation:Proton Antiporter-1 (CPA1) family ;
Tissue Specificity Kidney and intestine.
Sequence
MVLRSGICGLSPHRIFPSLLVVVALVGLLPVLRSHGLQLSPTASTIRSSEPPRERSIGDV
TTAPPEVTPESRPVNHSVTDHGMKPRKAFPVLGIDYTHVRTPFEISLWILLACLMKIGFH
VIPTISSIVPESCLLIVVGLLVGGLIKGVGETPPFLQSDVFFLFLLPPIILDAGYFLPLR
QFTENLGTILIFAVVGTLWNAFFLGGLMYAVCLVGGEQINNIGLLDNLLFGSIISAVDPV
AVLAVFEEIHINELLHILVFGESLLNDAVTVVLYHLFEEFANYEHVGIVDIFLGFLSFFV
VALGGVLVGVVYGVIAAFTSRFTSHIRVIEPLFVFLYSYMAYLSAELFHLSGIMALIASG
VVMRPYVEANISHKSHTTIKYFLKMWSSVSETLIFIFLGVSTVAGSHHWNWTFVISTLLF
CLIARVLGVLGLTWFINKFRIVKLTPKDQFIIAYGGLRGAIAFSLGYLLDKKHFPMCDLF
LTAIITVIFFTVFVQGMTIRPLVDLLAVKKKQETKRSINEEIHTQFLDHLLTGIEDICGH
YGHHHWKDKLNRFNKKYVKKCLIAGERSKEPQLIAFYHKMEMKQAIELVESGGMGKIPSA
VSTVSMQNIHPKSLPSERILPALSKDKEEEIRKILRNNLQKTRQRLRSYNRHTLVADPYE
EAWNQMLLRRQKARQLEQKINNYLTVPAHKLDSPTMSRARIGSDPLAYEPKEDLPVITID
PASPQSPESVDLVNEELKGKVLGLSRDPAKVAEEDEDDDGGIMMRSKETSSPGTDDVFTP
APSDSPSSQRIQRCLSDPGPHPEPGEGEPFFPKGQ
Function This transporter mediates and participates in regulating pH value to eliminate acids generated by active metabolism or to combat adverse environmental conditions.
Endogenous Substrate(s) Na+; H+
TCDB ID
2.A.36.1.13
Gene ID
6548
KEGG Pathway
cAMP signaling pathway (hsa04024 )
Cardiac muscle contraction (hsa04260 )
Adrenergic signaling in cardiomyocytes (hsa04261 )
Apelin signaling pathway (hsa04371 )
Regulation of actin cytoskeleton (hsa04810 )
Thyroid hormone signaling pathway (hsa04919 )
Salivary secretion (hsa04970 )
Gastric acid secretion (hsa04971 )
Pancreatic secretion (hsa04972 )
Bile secretion (hsa04976 )
Proteoglycans in cancer (hsa05205 )
Reactome Pathway
Sodium/Proton exchangers (R-HSA-425986 )
Hyaluronan uptake and degradation (R-HSA-2160916 )

Molecular Expression Atlas (MEA) of This DTP

Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This DTP
Disease Name ICD 11 Studied Tissue p-value Fold-Change Z-score
Acute myelocytic leukaemia 2B33.1 Bone marrow 1.09E-62 7.35E-01 3.06E+00
Adrenocortical carcinoma 2D11.Z Kidney 3.92E-02 8.40E-02 2.87E-01
Alopecia ED70 Skin from scalp 1.70E-01 5.89E-02 1.62E-01
Alzheimer's disease 8A20 Entorhinal cortex 2.27E-09 -4.18E-01 -7.05E-01
Ankylosing spondylitis FA92.0 Pheripheral blood 5.12E-01 -1.39E-02 -2.99E-02
Aortic stenosis BB70 Calcified aortic valve 4.65E-01 4.28E-02 1.35E-01
Apnea 7A40 Hyperplastic tonsil 1.54E-01 -2.67E-01 -1.01E+00
Arthropathy FA00-FA5Z Peripheral blood 1.90E-01 8.27E-02 3.50E-01
Asthma CA23 Nasal and bronchial airway 1.65E-02 2.75E-01 3.36E-01
Atopic dermatitis EA80 Skin 1.02E-02 1.15E-01 5.03E-01
Autism 6A02 Whole blood 8.40E-01 7.28E-03 2.67E-02
Autoimmune uveitis 9A96 Peripheral monocyte 9.55E-01 -3.20E-02 -1.40E-01
Autosomal dominant monocytopenia 4B04 Whole blood 8.18E-01 3.00E-01 2.81E-01
Bacterial infection of gingival 1C1H Gingival tissue 5.01E-02 7.92E-02 2.55E-01
Batten disease 5C56.1 Whole blood 6.18E-01 3.63E-02 1.20E-01
Behcet's disease 4A62 Peripheral blood 9.44E-01 4.76E-02 1.59E-01
Bipolar disorder 6A60-6A6Z Prefrontal cortex 9.48E-02 -6.03E-02 -3.28E-01
Bladder cancer 2C94 Bladder tissue 2.19E-03 4.76E-01 1.57E+00
Breast cancer 2C60-2C6Z Breast tissue 1.14E-18 1.93E-01 4.37E-01
Cardioembolic stroke 8B11.20 Whole blood 9.07E-01 6.78E-03 1.39E-02
Cervical cancer 2C77 Cervical tissue 1.60E-01 7.01E-02 2.51E-01
Childhood onset rheumatic disease FA20.Z Peripheral blood 2.18E-01 3.09E-02 1.37E-01
Chronic hepatitis C 1E51.1 Whole blood 5.32E-01 1.15E-01 4.75E-01
Chronic obstructive pulmonary disease CA22 Lung tissue 2.28E-01 8.83E-02 3.68E-01
Chronic obstructive pulmonary disease CA22 Small airway epithelium 2.96E-03 -1.56E-01 -6.72E-01
Chronic rhinosinusitis CA0A Sinus mucosa tissue 1.78E-01 0.00E+00 0.00E+00
Colon cancer 2B90 Colon tissue 1.29E-43 3.63E-01 1.44E+00
Coronary artery disease BA80-BA8Z Peripheral blood 4.22E-01 4.62E-02 2.43E-01
Diffuse large B-cell lymphoma 2A81 Tonsil tissue 7.91E-01 4.76E-02 7.90E-02
Endometriosis GA10 Endometrium tissue 4.03E-01 1.65E-01 3.37E-01
Familial hypercholesterolemia 5C80.00 Peripheral blood 7.11E-01 5.58E-02 3.44E-01
Familial hypercholesterolemia 5C80.00 Whole blood 1.27E-01 -1.95E-01 -1.02E+00
Gastric cancer 2B72 Gastric tissue 8.76E-01 4.12E-02 5.53E-02
Glioblastopma 2A00.00 Nervous tissue 8.42E-03 -7.08E-02 -1.27E-01
Glioma 2A00.0Y-2A00.0Z White matter tissue 7.04E-02 5.57E-01 9.18E-01
Head and neck cancer 2D42 Head and neck tissue 4.99E-09 1.65E-01 6.97E-01
HIV-associated neurocognitive impairment 8A2Y-8A2Z White matter tissue 2.08E-01 -2.36E-01 -4.92E-01
Huntington's disease 8A01.10 Whole blood 4.01E-01 1.18E-01 6.67E-01
Idiopathic pulmonary fibrosis CB03.4 Lung tissue 1.15E-01 3.59E-01 1.45E+00
Immunodeficiency 4A00-4A20 Peripheral blood 1.46E-01 5.79E-02 4.95E-01
Influenza 1.00E+30 Whole blood 9.80E-01 -2.52E-01 -6.82E-01
Interstitial cystitis GC00.3 Bladder tissue 3.97E-01 1.12E-01 3.74E-01
Intracranial aneurysm 8B01.0 Intracranial artery 3.57E-02 2.87E-01 1.21E+00
Irritable bowel syndrome DD91.0 Rectal colon tissue 8.91E-01 4.59E-04 1.35E-03
Ischemic stroke 8B11 Peripheral blood 2.81E-01 1.37E-02 5.03E-02
Juvenile idiopathic arthritis FA24 Peripheral blood 3.90E-01 -2.14E-02 -4.18E-02
Lateral sclerosis 8B60.4 Cervical spinal cord 3.54E-01 1.54E-01 4.03E-01
Lateral sclerosis 8B60.4 Skin 4.70E-01 4.09E-02 1.25E-01
Liver cancer 2C12.0 Liver tissue 3.04E-06 -2.60E-01 -9.08E-01
Liver failure DB99.7-DB99.8 Liver tissue 5.77E-01 -9.00E-02 -4.43E-01
Lung cancer 2C25 Lung tissue 1.19E-85 5.75E-01 2.12E+00
Lupus erythematosus 4A40 Whole blood 9.93E-01 7.95E-02 1.13E-01
Major depressive disorder 6A70-6A7Z Whole blood 1.59E-01 -4.26E-02 -1.07E-01
Major depressive disorder 6A70-6A7Z Hippocampus 5.54E-01 8.04E-02 4.05E-01
Melanoma 2C30 Skin 4.67E-01 -4.54E-01 -5.00E-01
Multiple myeloma 2A83.1 Bone marrow 4.91E-01 3.99E-02 2.10E-01
Multiple myeloma 2A83.1 Peripheral blood 6.02E-01 3.60E-02 8.67E-02
Multiple sclerosis 8A40 Plasmacytoid dendritic cells 4.01E-02 -2.78E-01 -1.55E+00
Myelodysplastic syndrome 2A36-2A3Z Bone marrow 1.63E-02 -1.22E-01 -5.14E-01
Myelofibrosis 2A20.2 Whole blood 6.08E-04 -2.78E-01 -1.62E+00
Myocardial infarction BA41-BA50 Peripheral blood 1.08E-01 1.16E-01 1.56E-01
Myopathy 8C70.6 Muscle tissue 9.77E-01 -2.72E-02 -8.87E-02
Neonatal sepsis KA60 Whole blood 8.78E-01 -4.01E-02 -1.59E-01
Neuroectodermal tumour 2A00.11 Brain stem tissue 6.89E-03 -3.16E-01 -1.07E+00
Non-alcoholic fatty liver disease DB92 Liver tissue 9.14E-01 5.44E-02 2.44E-01
Obesity related type 2 diabetes 5A11 Omental adipose tissue 6.38E-01 2.08E-02 2.46E-01
Olive pollen allergy CA08.00 Peripheral blood 2.54E-01 -4.32E-01 -9.66E-01
Oral cancer 2B6E Oral tissue 8.16E-06 2.43E-01 9.81E-01
Osteoarthritis FA00-FA0Z Synovial tissue 9.52E-01 -2.93E-01 -7.35E-01
Osteoporosis FB83.1 Bone marrow 7.12E-01 -1.66E-01 -3.56E-01
Ovarian cancer 2C73 Ovarian tissue 6.71E-03 2.79E-01 9.32E-01
Pancreatic cancer 2C10 Pancreas 8.20E-02 3.45E-02 8.70E-02
Parkinson's disease 8A00.0 Substantia nigra tissue 1.18E-01 -7.87E-02 -4.64E-01
Pediatric respiratory syncytial virus infection CA40.11 Peripheral blood 1.36E-01 -7.05E-02 -2.14E-01
Pituitary cancer 2D12 Pituitary tissue 9.84E-03 2.92E-01 8.49E-01
Pituitary gonadotrope tumour 2D12 Pituitary tissue 1.88E-03 6.79E-01 1.79E+00
Polycystic ovary syndrome 5A80.1 Vastus lateralis muscle 4.39E-02 1.62E-01 1.12E+00
Polycythemia vera 2A20.4 Whole blood 1.66E-03 -1.13E-01 -6.80E-01
Pompe disease 5C51.3 Biceps muscle 1.52E-01 -2.49E-01 -9.86E-01
Preterm birth KA21.4Z Myometrium 7.32E-01 0.00E+00 0.00E+00
Prostate cancer 2C82 Prostate 2.11E-09 1.28E+00 2.46E+00
Psoriasis EA90 Skin 2.65E-11 2.93E-01 7.82E-01
Rectal cancer 2B92 Rectal colon tissue 2.92E-02 2.29E-01 9.09E-01
Renal cancer 2C90-2C91 Kidney 1.13E-01 9.88E-02 5.45E-01
Retinoblastoma 2D02.2 Uvea 9.90E-02 -1.94E-01 -1.04E+00
Rheumatoid arthritis FA20 Synovial tissue 7.14E-01 -2.33E-03 -4.77E-03
Rhinovirus infection CA42.1 Nasal epithelium tissue 1.62E-01 7.28E-03 3.03E-02
Schizophrenia 6A20 Prefrontal cortex 8.08E-02 1.17E-02 4.44E-02
Schizophrenia 6A20 Superior temporal cortex 1.28E-02 -8.56E-02 -5.46E-01
Scleroderma 4A42.Z Whole blood 2.27E-01 9.75E-02 5.12E-01
Seizure 8A60-8A6Z Whole blood 3.40E-01 -9.85E-02 -4.24E-01
Sensitive skin EK0Z Skin 7.88E-01 0.00E+00 0.00E+00
Sepsis with septic shock 1G41 Whole blood 4.10E-01 2.29E-02 6.98E-02
Shwachman-Diamond syndrome 3A70.0 Bone marrow 7.76E-02 -3.90E-01 -7.24E-01
Sickle cell disease 3A51.0-3A51.3 Peripheral blood 4.90E-02 6.29E-02 4.06E-01
Simpson golabi behmel syndrome LD2C Adipose tissue 8.09E-01 2.28E-02 6.37E-02
Sjogren's syndrome 4A43.2 Salivary gland tissue 5.53E-02 3.07E-01 1.80E+00
Skin cancer 2C30-2C3Z Skin 8.42E-07 2.19E-01 4.31E-01
Thrombocythemia 3B63 Whole blood 4.68E-01 -2.14E-02 -1.21E-01
Thrombocytopenia 3B64 Whole blood 9.14E-01 -3.40E-01 -3.45E-01
Thyroid cancer 2D10 Thyroid 4.68E-17 3.35E-01 1.05E+00
Tibial muscular dystrophy 8C75 Muscle tissue 7.26E-01 9.54E-02 2.51E-01
Tuberous sclerosis complex LD2D.2 Perituberal tissue 8.02E-02 -1.65E-01 -1.02E+00
Type 2 diabetes 5A11 Liver tissue 6.69E-01 9.12E-03 3.15E-02
Ureter cancer 2C92 Urothelium 3.82E-01 -5.41E-02 -1.96E-01
Uterine cancer 2C78 Endometrium tissue 2.19E-14 4.12E-01 1.05E+00
Vitiligo ED63.0 Skin 6.44E-01 -1.87E-02 -3.93E-02
------------------------------------------------------------------------------------
⏷ Show the Full List of Expression Under 107 Diseases

The Drug Therapeutic Target (DTT) Role of This DTP

DTP DTT Name Sodium/hydrogen exchanger 1 (SLC9A1) DTT Info
DTP DTT Type Clinical trial
1 Clinical Trial Drug(s) Targeting This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zoniporide hydrochloride DM8L7JD Angina pectoris BA40 Phase 3 [1]
------------------------------------------------------------------------------------
3 Discontinued Drug(s) Targeting This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
CARIPORIDE DMV2DY3 Angina pectoris BA40 Discontinued in Phase 2 [2]
ENIPORIDE DME7OCX Cardiac arrhythmias BC9Z Discontinued in Phase 2 [3]
HOE-694 DML0B97 Heart arrhythmia BC65 Terminated [4]
------------------------------------------------------------------------------------
16 Investigative Drug(s) Targeting This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
5'-(N-ethyl-N-isopropyl)amiloride DM3TPMO Discovery agent N.A. Investigative [5]
BIIB-513 DML4DQ3 Myocardial infarction BA41-BA43 Investigative [6]
Homoserine Lactone DMTKN4A Discovery agent N.A. Investigative [7]
N-(3-Methanesulfonyl-4-methoxy-benzoyl)-guanidine DM0H8CK Discovery agent N.A. Investigative [4]
N-(3-Methanesulfonyl-4-methyl-benzoyl)-guanidine DMSVQJP Discovery agent N.A. Investigative [4]
N-(4-Bromo-3-methanesulfonyl-benzoyl)-guanidine DMC28SN Discovery agent N.A. Investigative [4]
N-(4-Chloro-3-methanesulfonyl-benzoyl)-guanidine DMFG6MU Discovery agent N.A. Investigative [4]
N-(4-Cyano-3-methanesulfonyl-benzoyl)-guanidine DMGI9EA Discovery agent N.A. Investigative [4]
N-(5-m-Tolyl-furan-2-carbonyl)-guanidine DMS2X69 Discovery agent N.A. Investigative [8]
N-(5-Methanesulfonyl-2-methyl-benzoyl)-guanidine DM91463 Discovery agent N.A. Investigative [4]
N-(5-o-Tolyl-furan-2-carbonyl)-guanidine DMFNZSL Discovery agent N.A. Investigative [8]
N-(5-Phenyl-furan-2-carbonyl)-guanidine DMNU68D Discovery agent N.A. Investigative [8]
N-[2-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine DMI9GQV Discovery agent N.A. Investigative [9]
N-[4-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine DMT6LX9 Discovery agent N.A. Investigative [9]
N-[5-(2-Ethyl-phenyl)-furan-2-carbonyl]-guanidine DMP5A8K Discovery agent N.A. Investigative [8]
N-[5-(2-Nitro-phenyl)-furan-2-carbonyl]-guanidine DMZ9V18 Discovery agent N.A. Investigative [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 16 Investigative Drug(s)

References

1 Zoniporde: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1). Cardiovasc Drug Rev. 2003 Spring;21(1):17-32.
2 Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives. Eur J Med Chem. 2009 Sep;44(9):3771-6.
3 Bicyclic acylguanidine Na+/H+ antiporter inhibitors. J Med Chem. 1998 Sep 10;41(19):3736-47.
4 (2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na+/H+ antiporter inhibitors. J Med Chem. 1997 Jun 20;40(13):2017-34.
5 NHE1 inhibition by amiloride- and benzoylguanidine-type compounds. Inhibitor binding loci deduced from chimeras of NHE1 homologues with endogenous ... J Biol Chem. 2007 Jul 6;282(27):19716-27.
6 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 948).
7 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
8 (5-Arylfuran-2-ylcarbonyl)guanidines as cardioprotectives through the inhibition of Na+/H+ exchanger isoform-1. J Med Chem. 2005 Apr 21;48(8):2882-91.
9 Benzimidazol-2-yl or benzimidazol-2-ylthiomethyl benzoylguanidines as novel Na+/H+ exchanger inhibitors, synthesis and protection against ischemic-... Bioorg Med Chem Lett. 2007 May 1;17(9):2430-3.